The US Food and Drug Administration (FDA) has approved Klygefa (gefurulimab) for the treatment of generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody positive. gMG is a chronic autoimmune neuromuscular disease...








International Rett Syndrome Foundation Works to Advance Research and Support Families
CheckRare 80 minutes ago